Cargando…
ACTIVating Resources for the COVID-19 Pandemic: In Vivo Models for Vaccines and Therapeutics
The Preclinical Working Group of Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV), a public-private partnership spearheaded by the National Institutes of Health, has been charged with identifying, prioritizing, and communicating SARS-CoV-2 preclinical resources. Reviewing SARS-Co...
Autores principales: | Hewitt, Judith A., Lutz, Cathleen, Florence, William C., Pitt, M. Louise M., Rao, Srinivas, Rappaport, Jay, Haigwood, Nancy L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528903/ https://www.ncbi.nlm.nih.gov/pubmed/33152279 http://dx.doi.org/10.1016/j.chom.2020.09.016 |
Ejemplares similares
-
Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19
por: Sempowski, Gregory D., et al.
Publicado: (2020) -
Achieving Global Vaccine Equity: The Case for an International
Pandemic Treaty
por: Jecker, Nancy S.
Publicado: (2022) -
Redefining environmental exposure for disease etiology
por: Rappaport, Stephen M.
Publicado: (2018) -
Farm animal genetic resources and the COVID-19 pandemic
por: Gandini, Gustavo, et al.
Publicado: (2021) -
The Infectious Diseases Act and Resource Allocation during the COVID-19 Pandemic in Bangladesh
por: Siraj, Md. Sanwar, et al.
Publicado: (2020)